Back to the Top 100

No. 31 Investors

Jorge Conde

General Partner, Andreessen HorowitzUnited States

An investor focusing on the convergence of biology, computing, and technology.

Find on LinkedIn

The Signal

His deep insights into genomic sequencing and synthetic biology guide investment strategies at the absolute forefront of computational healthcare, advanced medicine, and molecular technology.

Who Jorge Conde is

An investor focusing on the convergence of biology, computing, and technology.

His deep insights into genomic sequencing and synthetic biology guide investment strategies at the absolute forefront of computational healthcare, advanced medicine, and molecular technology.

Loading the full dossier

At a glance

Role
General Partner
Organisation
Andreessen Horowitz
Platforms
LinkedIn, Podcast, X
Based in
United States, North America
Influence Score 88.6editorial estimate, see how it is built
Reach (25% weight)88

Audience size across LinkedIn, X, YouTube, podcasts and newsletters.

Engagement (20% weight)87

How much the audience actually reacts, comments, shares and subscribes.

Credibility (25% weight)94

Clinical, research, operating or investing track record behind the commentary.

Consistency (15% weight)81

Publishing cadence and how reliably they show up with original work.

Industry impact (15% weight)90

Whether decision makers, policy and capital actually move on what they say.

Scores are subjective editorial estimates compiled by our research desk from public profiles and published work. They are opinion, not measurement, and they are not a judgement of any person's character or ability.

Also in Investors

This profile is compiled by our research desk from public sources and is published as editorial commentary. Want a correction, an update, or your profile removed? and see our corrections and removals policy.